Providence Regional Cancer System-Centralia — Centralia, Washington

Providence Regional Cancer System-Centralia is a clinical research site located in Centralia, Washington, United States 98531.

Crixeo Health Trust Score: 88/100 (GOOD). This profile has not yet been claimed by the site owner.

Providence Regional Cancer System-Centralia has participated in 226 clinical trials with 138 currently active.

Therapeutic areas: Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Sponsors: GOG Foundation, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 88/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Providence Regional Cancer System-Centralia?

Providence Regional Cancer System-Centralia has a Crixeo Trust Score of 88/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Providence Regional Cancer System-Centralia conducted?

Providence Regional Cancer System-Centralia has 226 clinical trials on record, with 138 currently active. Their work covers Choriocarcinoma, FIGO Stage I Gestational Trophoblastic Tumor, FIGO Stage II Gestational Trophoblastic Tumor.

Is Providence Regional Cancer System-Centralia accredited by Crixeo Health?

Providence Regional Cancer System-Centralia has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Providence Regional Cancer System-Centralia?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.